Table 1.
Patient characteristics.
| No. | Sex | Age | F-U (mos) | Location | Campanacci grade | Outcome | L/R | D/M | K-L grade on latest F-U | Complications | Additional therapy |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | F | 42 | 38 | Dist femur | II | CDF | No | No | 1 | − | |
| 2 | M | 27 | 44 | Prox humerus | II | CDF | No | No | 0 | − | |
| 3 | F | 20 | 122 | Dist femur | II | AWD | Yes | No | 0 | − | Denosumab |
| 4 | M | 15 | 74 | Prox humerus | II | CDF | No | No | 0 | − | |
| 5 | M | 25 | 30 | Patella | I | CDF | No | No | 0 | − | |
| 6 | F | 14 | 70 | Prox humerus | I | CDF | No | No | 0 | − | |
| 7 | F | 19 | 67 | Dist femur | II | CDF | No | No | 0 | − | |
| 8 | M | 22 | 85 | Prox tibia | II | AWD | Yes | No | 0 | − | Denosumab |
| 9 | M | 29 | 38 | Prox fibula | II | CDF | No | No | 1 | − | |
| 10 | F | 42 | 48 | Prox tibiar | II | CDF | No | No | 1 | − | |
| 11 | M | 47 | 24 | Dist radius | II | CDF | No | No | 0 | − | |
| 12 | M | 58 | 12 | Dist femur | II | CDF | No | No | 1 | − | |
| 13 | F | 56 | 23 | Dist radius | II | CDF | No | No | 1 | − | |
| 14 | M | 32 | 20 | Dist femur | II | CDF | No | No | 1 | − | |
| 15 | M | 9 | 12 | Prox tibia | II | CDF | No | No | 0 | − | |
| 16 | F | 46 | 15 | Dist tibia | II | AWD | Yes | No | 1 | − | Re-curettage, denosumab |
AWD = alive with disease, CDF = continuous disease free, D/M = distant metastasis, Dist = distal, F = female, F-U = follow-up, K-L = Kellgren-Lawrence classification, L/R = local recurrence, M = male, mos = months, no = number, prox = proximal, Surg = surgery.